Preclinical biotech developing protein degradation therapies for advanced cancers.
Industry: Health Care
First Day Return: +0.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/30/2018 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $120 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/26/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $120 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New Haven, CT, United States |
Founded | 2013 |
Employees at IPO | 72 |
Website www.arvinas.com |